Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5832.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,2732.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1816.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,728.0,1.0,=,2.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1087.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,334.0,1.0,=,3.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,874.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,485.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,843.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,472.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,650.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,290.0,1.0,=,2.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5658.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,3076.0,1.0,=,1.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,4310.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,3279.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3383.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,775.0,1.0,=,4.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2292.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,579.0,1.0,=,4.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2247.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,918.0,1.0,=,2.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2071.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,908.0,1.0,=,2.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1973.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,676.0,1.0,=,2.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1865.0,1.0,Kappa,95,T95I + G142D + E154K + L452R + E484Q + P681R + Q1071H,1,=,964.0,1.0,=,1.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5832.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,3830.0,1.0,=,1.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1816.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1469.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1087.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,338.0,1.0,=,3.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,874.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,408.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,843.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,743.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,650.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,418.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,5658.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,2456.0,1.0,=,2.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,4310.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,3110.0,1.0,=,1.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,3383.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,624.0,1.0,=,5.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2292.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,756.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2247.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1403.0,1.0,=,1.6
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,2071.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1348.0,1.0,=,1.5
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1973.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,574.0,1.0,=,3.4
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2B,None,mRNA-1273,2,1m,Human,Wild Type (B.1),=,1865.0,1.0,Kappa,142,G142D + E154K + V382L + L452R + E484Q + P681R + Q1071H + D1153Y,1,=,1360.0,1.0,=,1.4